No Data
No Data
No Data
No Data
No Data
InMode Defends Its Feminine Rejuvenation Patent Against BTL Industries' Review Request
InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, responded to the recent petition to the U.S. Patent & Trademark Office filed by BTL Industries, Inc., in which
BenzingaApr 15 07:08 ET
Express News | Inmode Responds to Btl Petition for Inter Partes Review of Patent Inmode Is Asserting Against Btl
Moomoo 24/7Apr 15 07:02 ET
InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, responded to the recent petition to the U.S. Patent &...
PR NewswireApr 15 07:00 ET
Barclays Adjusts Price Target on InMode to $33 From $34, Maintains Overweight Rating
InMode (INMD) has an average outperform rating and price target range of $21 to $33, according to analysts polled by Capital IQ. Price: 18.18, Change: -0.29, Percent Change: -1.57
MT NewswiresApr 12 10:24 ET
InMode Is Maintained at Overweight by Barclays
InMode Is Maintained at Overweight by Barclays
Dow JonesApr 12 10:09 ET
Express News | Inmode Ltd : Barclays Cuts Target Price to $33 From $34
Moomoo 24/7Apr 12 05:45 ET
No Data
No Data